BioMerieux Total Liabilities 2017-2024 | BMXMF
BioMerieux total liabilities from 2017 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- BioMerieux total liabilities for the quarter ending December 31, 2024 were $1.687B, a 3.79% increase year-over-year.
- BioMerieux total liabilities for 2024 were $1.687B, a 3.43% increase from 2023.
- BioMerieux total liabilities for 2023 were $1.631B, a 0.29% increase from 2022.
- BioMerieux total liabilities for 2022 were $1.626B, a 4.68% decline from 2021.
| BioMerieux Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,687 |
| 2023 | $1,631 |
| 2022 | $1,626 |
| 2021 | $1,706 |
| 2020 | $1,652 |
| 2019 | $1,711 |
| 2018 | $1,637 |
| 2017 | $1,417 |
| 2016 | $1,557 |
| 2015 | $0 |
| BioMerieux Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,687 |
| 2023-12-31 | $1,631 |
| 2023-06-30 | $1,515 |
| 2022-12-31 | $1,626 |
| 2022-06-30 | $1,625 |
| 2021-12-31 | $1,706 |
| 2021-06-30 | $1,697 |
| 2020-12-31 | $1,652 |
| 2019-12-31 | $1,711 |
| 2019-06-30 | $1,720 |
| 2018-12-31 | $1,637 |
| 2018-06-30 | $1,394 |
| 2017-12-31 | $1,417 |
| 2017-06-30 | $1,412 |
| 2016-12-31 | $1,557 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.861B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.821B | 26.97 |
| CVS Health (CVS) | United States | $84.326B | 10.48 |
| Elevance Health (ELV) | United States | $78.255B | 10.10 |
| Cencora (COR) | United States | $58.178B | 20.24 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.086B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
| Solventum (SOLV) | United States | $12.836B | 13.59 |
| CochLear (CHEOY) | Australia | $12.824B | 0.00 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.802B | 20.31 |
| Viatris (VTRS) | United States | $10.833B | 3.72 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
| HealthEquity (HQY) | United States | $8.646B | 37.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
| BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
| Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
| Concentras Parent (CON) | United States | $2.619B | 15.13 |
| Organon (OGN) | United States | $2.576B | 2.74 |
| Progyny (PGNY) | United States | $2.038B | 44.87 |
| Ardent Health (ARDT) | United States | $1.981B | 8.45 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Premier (PINC) | United States | $1.778B | 13.49 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| CareDx (CDNA) | United States | $1.129B | 17.64 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| Nutex Health (NUTX) | United States | $0.643B | 9.73 |
| Embecta (EMBC) | United States | $0.619B | 4.17 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.546B | 0.00 |
| LifeMD (LFMD) | United States | $0.535B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| So-Young (SY) | China | $0.440B | 0.00 |
| Omada Health (OMDA) | $0.434B | 0.00 | |
| Enhabit (EHAB) | United States | $0.368B | 30.29 |
| Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Oncology Institute (TOI) | United States | $0.216B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |